Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on July 20, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

NCI Radiation Oncology Branch Acquisition of Elekta Unity Linac System for Radiation Therapy

Closed
NIH-NOI-26-PCA-NCI-09516Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 339112
New
Federal
SPS Sterilizer
Solicitation # 36C24526Q0758
Solicitation 36C24526Q0758 is a Firm-Fixed Price purchase order for the procurement and installation of five new steam sterilizers and five switch-over control systems for the Sterile Processing Service at the Baltimore VA Medical Center. The project includes the de-installation and disposal of existing equipment, facility work such as plumbing relocation and flooring leveling, and system validation performed by an OEM-trained representative. To ensure continuous operations, installation must be completed in two phases, with the first two units installed followed by the remaining three. While Belimed is the brand name of reference, the government will accept fully equivalent systems that meet specific dimensions and a minimum chamber volume of 275 liters. The award will be granted to the responsible quoter determined to be most advantageous based on technical capability, price, and past performance. Mandatory submission requirements include a detailed line-item worksheet, manufacturer authorization letters for distributors, and specific certifications regarding Service Contract Labor Standards. Delivery must be FOB Destination and completed within 12 months of the award. Contractors are required to maintain general liability insurance of 500,000 dollars per occurrence and comply with strict security prohibitions regarding covered telecommunications equipment. Invoices are to be submitted electronically in arrears upon the receiving and acceptance of goods and services.
245-NETWORK Contract Office 5 (36C245)

POSTED

1 day ago

DEADLINE

in 2 days
NAICS: 339112
New
Federal
Automated Endoscope Reprocessor (BAMC, San Antonio, Texas)
Solicitation # HT940826QE040
Solicitation HT940826QE040 is a combined synopsis and request for quote issued by the Defense Health Agency for the procurement and installation of five automated endoscope reprocessors (AERs) at Brooke Army Medical Center in San Antonio, Texas. The scope of work includes the installation of units across the Gastroenterology, Pulmonary, and Pediatrics departments, as well as the deinstallation and hauling away of twelve existing Olympus OER Pro/Elite systems. The required AERs must be FDA Class II Medical Devices with 510(k) premarket notification, featuring dual-basin designs with cycle times of approximately 22 minutes and compliance with AS/NI/AAMI ST91 and CDC infection prevention guidelines. The contract also requires the provision of compatible hookup blocks, water filtration assemblies, vapor management accessories, a one-year commercial warranty, and comprehensive on-site clinical training for staff. This is a firm-fixed-price acquisition that is not set aside for small business concerns, though it allows for HUBZone price evaluation preferences. Award will be based on the most advantageous offer, considering price, technical literature demonstrating compliance with specifications, and the delivery and installation timeframe. All items must be delivered by November 15, 2026, and must adhere to DoD item unique identification and marking standards per MIL-STD-130 and MIL-STD-129. Quotes must be submitted electronically to the designated points of contact by September 16, 2026. Payment will be processed electronically through the Wide Area WorkFlow (WAWF) system.
Defense Health Agency

POSTED

1 day ago

DEADLINE

in 4 days

AI Contract Overview

Show more

The National Cancer Institute within the National Institutes of Health intends to award a sole-source, firm-fixed-price contract to Elekta, Inc. for the acquisition of a fully integrated 1.5 Tesla magnetic resonance-guided linear accelerator system, critical for advanced radiation therapy and clinical research. This system must include a 7 MV photon beam, a 160-leaf multileaf collimator, an onboard 1.5T or higher MRI scanner with specialized imaging protocols for radiotherapy, diffusion weighted imaging capability, motion-adaptive treatment functionality, a low-attenuation MR receive coil, a dedicated MRI console, an indexable patient positioning system, and comprehensive quality assurance software. The requirement stems from the necessity of a single integrated platform that eliminates geometric uncertainties by combining imaging and treatment in one coordinate system, which no other commercially available system currently satisfies. Sole-source justification is supported by statutory authority under 41 U.S.C. 3304(a)(1) and FAR 6.302-1, as Elekta is the only entity capable of delivering a system meeting all minimum technical specifications with full OEM installation, commissioning, training, and warranty support. Responses to this notice are not mandatory but are invited from any responsible source that believes it can meet the Government’s unique requirements. Interested parties must submit a capability statement no later than July 30, 2026, at 11:00 AM Eastern Time, limited to ten pages and including company details, UEI number, point of contact, a technical description of the proposed system, evidence of compliance with all specified characteristics, proof of OEM authorization, and relevant past performance. The Government will evaluate submissions to determine whether competition is feasible; failure to demonstrate full alignment with the minimum requirements will not result in further consideration. This notice does not constitute a solicitation, nor will the Government assume responsibility for any costs associated with response preparation. All correspondence and submissions should be directed to Linda Smith or Danielle Tines at the provided email addresses.

General Info

Sole-source contract to Elekta for integrated 1.5T MR-guided linear accelerator with advanced radiotherapy capabilities.

Agency

Department Of Health And Human Services → National Institutes Of Health OlaoView Agency

NAICS

339112 - Surgical and Medical Instrument ManufacturingView NAICS

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

special-notice

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
Contacts2 people available
OfficeBETHESDA, MD, 20892, USA
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health Olao
View Agency Profile
Office AddressBETHESDA, MD, 20892, USA
Contacts

Full Description

Show more

Notice of Intent to Sole Source
Notice ID: NIH-NOI-26-PCA-NCI-09516


Agency / Office: Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI)


Notice Type: Special Notice


Posted Date: July 20, 2026
Response Date: July 30, 2026, 11:00 AM Eastern Time


NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing
PSC: 6515 – Medical and Surgical Instruments, Equipment, and Supplies


Contracting Office Address:
National Institutes of Health
National Cancer Institute
 


Description


This is a combined synopsis / notice of intent to sole source and is not a request for competitive quotations or proposals.


The National Institutes of Health (NIH), National Cancer Institute (NCI), on behalf of the Center for Cancer Research (CCR), Radiation Oncology Branch (ROB), intends to negotiate and award a sole-source firm-fixed-price contract to Elekta, Inc., 400 Perimeter Center Terrace NE, Suite 50, Atlanta, GA 30346, for the acquisition, delivery, installation, commissioning, training, and warranty of an integrated magnetic resonance-guided linear accelerator system.


The statutory authority for this proposed sole-source action is 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.


Requirement


The Government requires a fully integrated MR-guided linear accelerator system to support patient treatment and clinical research. The minimum salient characteristics include:


  • 7 Megavoltage (MV) photon beam
  • 160-leaf multileaf collimator (MLC)
  • Onboard 1.5 Tesla (or greater) magnetic resonance imaging system
  • Imaging protocols explicitly created for MR-guided external beam radiotherapy
  • Capability for Diffusion Weighted Imaging (DWI)
  • Capability for imaging and treating in the presence of patient motion
  • MR receive coil with low attenuation of the radiation beam
  • Dedicated MRI console for imaging guidance and control
  • Patient positioning system including flat table, comfort mattress, and indexable table
  • Quality assurance capabilities and supporting software
  • Site planning, delivery, installation, commissioning, training, and warranty

This equipment is mission-critical to patient treatment and clinical research because it enables high-resolution soft-tissue visualization and adaptive radiotherapy in a single integrated coordinate system, reducing geometric uncertainty associated with moving a patient between separate imaging and treatment systems.


Sole Source Basis


Based on market research, Elekta, Inc. is the only known responsible source capable of providing a commercially available, fully integrated 1.5 Tesla MR-guided linear accelerator system meeting the Government’s minimum needs.


The Government reviewed other systems in the broader radiation oncology market, including lower-field MR-guided systems, CBCT-based adaptive radiotherapy systems, and standalone MRI platforms. These alternatives do not satisfy the Government’s minimum requirement for a fully integrated 1.5T MR-Linac with the required imaging, treatment, adaptive planning, and OEM installation capabilities.


In addition, the proprietary nature of the system and the specialized site planning, shielding, installation, and commissioning requirements make Elekta the only responsible source for both the equipment and the associated implementation services.


Response Information


This notice is for informational purposes only. Any responsible source that believes it can meet the Government’s requirement may submit a capability statement for Government consideration.


Capability statements must clearly demonstrate the vendor’s ability to provide a commercially available, fully integrated 1.5 Tesla (or greater) MR-guided linear accelerator system meeting all minimum salient characteristics, including OEM-authorized delivery, installation, commissioning, training, and warranty support.


Responses must be submitted electronically no later than 11:00 AM Eastern Time on July 30, 2026.


Responses shall be limited to 10 pages and must include:


  1. Company name and address
  2. UEI number
  3. Point of contact name, email address, and telephone number
  4. Technical description of the proposed system
  5. Evidence that the proposed system meets all minimum salient characteristics
  6. Evidence of OEM authorization for sale, installation, and support
  7. Relevant past performance information for similar Federal or commercial installations

The Government will review all capability statements received by the closing date. A determination by the Government not to compete this proposed action based on responses to this notice is solely within the discretion of the Government.


Primary Point of Contact


Linda Smith
linda.smith2@nih.gov


Secondary Point of Contact


Danielle Tines
danielle.tines@nih.gov


Disclaimer


This notice does not constitute a solicitation, request for proposal, or request for quotation. The Government is not responsible for any costs incurred in responding to this notice.


More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS